DEXIS AI Revolutionizes Pathology Detection with FDA-Cleared 2D Intraoral X-Rays!

DEXIS is proud to announce FDA 510(k) Clearance for its revolutionary dental findings AI on 2D intraoral X-ray images. The next generation of DEXIS software, DTX Studio Clinic, is the first and only imaging solution to offer six types of pathological dental findings on periapical and bitewing intraoral radiograph images, seamlessly integrated into one on-premise imaging software. With DTX Studio Clinic, dental offices now have access to an imaging acquisition, diagnosis, and treatment planning software that is used by over 10,000 dental practices worldwide.

DTX Studio Clinic is revolutionizing dental care with its advanced radiograph analysis technology, helping clinicians make more informed decisions. This cutting-edge system can detect a range of dental conditions, from caries to root canal defects and bone loss, and it provides a comprehensive view of the diagnosis and treatment plan to patients, helping to build trust and understanding while streamlining practice workflows.

DTX Studio Clinic has been revolutionizing dentistry with its AI-powered features, from the 2017 FDA clearance for its 3D virtual tooth setup algorithm to the 2021 clearance for automatic tooth position identification and automated sorting of full-mouth x-ray series, and most recently the 2022 clearance for fully automated mandibular nerve tracing on CBCT scans. This impressive series of accomplishments has earned DTX Studio Clinic back-to-back Cellerant Best of Class Technology Awards and has left dentists in awe.

Envista’s CEO Amir Aghdaei is proud to announce the newest release of DTX Studio Clinic, featuring enhanced built-in AI capabilities such as the identification of pathological dental findings. With this powerful tool, DEXIS is empowering dental practices to take advantage of digital dentistry, enabling them to work with greater efficiency and predictability to deliver the best possible patient outcomes.


Discover the power of DEXIS digital solutions to elevate your patient outcomes and boost confidence. From consultation to diagnosis, treatment to surgery, and even appliance delivery, our full portfolio of CBCT and Intraoral scanners, digital sensors, handheld x-ray systems, and DTX Studio Clinic software work seamlessly together to revolutionize the way you practice. Experience the convenience and efficiency of DEXIS and take your patient journey to the next level.

About Envista Holdings Corporation

Envista is a global family of more than 30 influential dental brands, such as DEXIS, Nobel Biocare, Ormco, and Kerr, that are united by a single purpose: to partner with dental professionals and improve lives through our industry-leading products, solutions, technology, and services.

Our comprehensive portfolio, ranging from dental implants to orthodontics and digital imaging, covers a wide variety of dentists’ clinical requirements to diagnose, treat, and even prevent dental conditions while also improving the beauty of a human smile.

Backed by the dependable Envista Business System (EBS) methodology, our knowledgeable leadership team, and a strong culture of improvement, innovation, and customer focus, Envista is well-equipped to address the end-to-end dental needs of professionals around the world. We are one of the biggest global dental products companies, with considerable positions in attractive segments of the dental products industry.

Leave a Comment